Beactica AB
UPPSALA, Sweden, December 6, 2011 -
Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Almac Discovery Ltd., an independent member of the Almac Group Ltd.
UPPSALA, Sweden, April 27, 2011 - Beactica, the leading Swedish fragment-based drug discovery company,
today announced that it has entered into an agreement with Janssen Research &
Development, a division of Janssen Pharmaceutica NV.
UPPSALA, Sweden - Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc.
